How to Get Pregnant at 45 Fast: What Actually Works

Getting pregnant at 45 is possible but comes with real challenges. Here’s what the fertility data shows and which options give you the best chances.

At 45, the honest answer is that no strategy makes pregnancy happen fast in the way you might hope. Natural conception rates fall below 1% per cycle at this age, IVF with your own eggs produces live births in roughly 1–5% of cycles, and even the most aggressive medical approaches cannot fully compensate for the age-related decline in egg quality. The one intervention that genuinely shifts the odds is donor egg IVF, which can yield live birth rates around 40% per transfer cycle. Understanding why these numbers look the way they do, and which strategies offer realistic chances versus false hope, is worth more than any shortcut.

Why Fertility Drops So Steeply by 45

The core issue is egg quality, not uterine health or general fitness. As eggs age, the cellular machinery that divides chromosomes during formation becomes less reliable. Chromosomal abnormalities affect more than 40% of eggs in women of advancing age, and by the mid-forties the rate is substantially higher than that. An embryo with the wrong number of chromosomes either fails to implant, miscarries, or in rare cases leads to a chromosomal condition. This is why so many pregnancies at this age end early: the risk of miscarriage at 45 and older exceeds 50%.

Meanwhile, ovarian reserve (the number of eggs remaining) has also dropped. Many women at 45 have very few eggs available per cycle. This combination of fewer eggs and a higher proportion of chromosomally abnormal eggs is what makes the biology so challenging. It is not about willpower, lifestyle, or supplementation: it is a fundamental shift in the raw material your body has to work with. Professional societies in reproductive medicine are explicit that both natural fertility and assisted reproduction success are significantly lower for women in their late thirties and forties, except when donor eggs are used.

Natural Conception and Basic Treatments

If you are 45 and hoping to conceive naturally or with low-tech interventions like ovulation-induction drugs and intrauterine insemination (IUI), the data is sobering. Studies of women over 40 show that live birth rates per cycle with clomiphene alone, IUI, or IUI plus injectable hormones are all extremely low, under 1%. That research was in women 40 and up; at 45 the numbers skew even lower. Reviews of the literature suggest that after a very brief trial of IUI, women 42 and older should proceed directly to IVF, and those beyond 41 should consider IVF the primary option from the start.

This does not mean natural pregnancy at 45 is impossible. Spontaneous pregnancies happen, and some women conceive without medical intervention. But if speed is your priority, spending months on approaches with sub-1% success rates costs you time you cannot afford. Every month at this age means fewer viable eggs and lower odds.

IVF With Your Own Eggs

IVF is significantly more effective than IUI for women over 40, but “more effective” has to be understood in context. For women at 43, one large 20-year study found a live birth rate of about 5% per cycle. At 44, that dropped to roughly 4%. At 45, the rate was 0% in that particular dataset, and at 46 and older it was about 4.5%, though on very small numbers. These are per-cycle numbers, meaning you would need multiple retrievals and transfers to accumulate a meaningful cumulative chance. A Markov model comparing treatment strategies estimated the cumulative live birth rate from standard autologous IVF at age 45 at just 1.6%.

Rare exceptions do exist. A case report documented a live birth from a woman who used her own eggs in her first IVF attempt at nearly 49 years old, following genetic testing of her embryos. That this warranted its own publication tells you how unusual it is. If you pursue IVF with your own eggs at 45, you are rolling the dice many times with very long odds per roll. Some clinics will support this if your ovarian reserve markers look reasonable, but most set an upper age limit: a survey of U.S. fertility clinics found the median maximum maternal age for autologous IVF was 45.

AMH, Ovarian Reserve, and What Testing Can Tell You

Before starting any IVF cycle, your clinic will likely test your anti-Müllerian hormone (AMH) level, a blood marker that reflects how many eggs your ovaries are likely to produce in a stimulated cycle. The results can guide expectations but should be interpreted carefully. In women with very low AMH, one study found that age, not small AMH differences, was the dominant factor driving pregnancy chances. In other words, two 45-year-olds with slightly different AMH values may have similar outcomes. That said, among older women specifically, those with meaningfully higher AMH levels did tend to have higher live birth rates than peers with very low AMH.

The practical takeaway: AMH gives you a sense of how many eggs a cycle might produce, but at 45 the quality of those eggs is the bigger bottleneck. A decent AMH result may mean more eggs per retrieval, but those eggs still carry the same age-related chromosomal risks. AMH cannot tell you whether any of those eggs will be normal.

Why Donor Eggs Change the Odds

The single most effective way to get pregnant at 45 is to use eggs from a younger donor. Because the donor’s eggs have far lower rates of chromosomal abnormalities, live birth rates with donor eggs remain remarkably high even for older recipients. A study of over 1,200 transfer cycles in women 45 and older found a stable live birth rate of about 40% per cycle, with cumulative rates around 58% for women 45–46 and 54% for women 50 and older, a difference that was not statistically significant.

There is a caveat. An analysis of nearly 28,000 fresh donor egg IVF cycles found that recipients 45 and older did experience a small but significant decline in implantation, clinical pregnancy, and live birth rates compared to younger recipients. The decline was real but modest, and the absolute rates remained far higher than anything achievable with a 45-year-old’s own eggs. This decline points to the role of the uterus itself, which is worth understanding.

The Aging Uterus Is Not Irrelevant

For years, the conventional wisdom was that egg quality explains nearly everything about age-related fertility decline, and the uterus stays more or less ready to carry a pregnancy. That view is being revised. Research now shows that the aging endometrium (the uterine lining where embryos implant) undergoes molecular and cellular changes that can impair receptivity. Studies of donor egg cycles, which control for egg quality, suggest that recipient age still matters: older recipients tend to have somewhat lower implantation and pregnancy rates. One retrospective cohort found that advanced maternal age independently decreased receptivity and euploid implantation success.

This is an emerging area of research and should not discourage you from pursuing donor eggs. The effect is small compared to the massive impact of egg quality. But it is one reason why success rates with donor eggs are not identical for a 30-year-old recipient and a 50-year-old recipient.

Genetic Testing of Embryos

Preimplantation genetic testing for aneuploidy (PGT-A) screens embryos for chromosomal abnormalities before transfer. For older women, this sounds like the obvious move: test the embryos, pick the normal ones, and avoid miscarriages. And on a per-transfer basis, the logic holds up. UK data showed that live birth rates per embryo transferred were significantly higher after PGT-A across all age groups, with the biggest advantage in women over 40, largely because fewer transfers were needed per successful birth.

The controversy emerges when you look at it from the cumulative perspective. A provocative analysis argued that for a woman over 40 with a small number of embryos, PGT-A can actually reduce total live birth potential. The reason is that biopsy and testing discard some embryos that, while flagged as abnormal, might have self-corrected and implanted. For a woman with only three embryos, PGT-A could lower her cumulative chance from about 20% to 14%, requiring roughly 43% more egg retrievals to restore the same odds. This is a genuine debate among reproductive endocrinologists, and the right choice depends on your specific situation, particularly how many embryos each retrieval produces and your tolerance for miscarriage risk.

DuoStim and Egg-Banking Strategies

When your ovaries produce very few eggs per cycle, a single retrieval may not yield any viable embryos. One strategy to accelerate the process is DuoStim, where two stimulations are performed in the same menstrual cycle, one in the follicular phase and one in the luteal phase, essentially doubling the collection opportunities in a single month. A case series using DuoStim in poor responders found that the second stimulation actually yielded more eggs on average than the first, about 3.7 versus 2.4.

The idea behind egg banking is to accumulate eggs or embryos across multiple retrievals before attempting any transfers. At 45, each individual retrieval may produce only a handful of eggs, most of which will be chromosomally abnormal. By banking, you increase the total pool and improve the odds of finding at least one viable embryo. DuoStim speeds up this accumulation by fitting two retrievals into one cycle. This approach is time-intensive and expensive, but for women determined to use their own eggs, it is one of the few ways to meaningfully improve cumulative odds.

Supplements and Experimental Therapies

You will find no shortage of supplement recommendations targeting egg quality. The most studied is coenzyme Q10 (CoQ10), which supports mitochondrial energy production in eggs. In animal models, CoQ10 reversed age-related declines in egg quality and ovarian reserve. In human IVF studies, CoQ10 supplementation before and during treatment improved fertilization rates, embryo quality, and reduced chromosomal abnormalities and egg fragmentation in women over 31. These are encouraging signals rather than proof of a game-changing effect. CoQ10 is inexpensive and low-risk, so many reproductive endocrinologists recommend it as a reasonable add-on. DHEA and vitamin D are also commonly suggested, though the evidence for each is thinner. None of these supplements will transform a 45-year-old’s eggs into 30-year-old eggs.

A more experimental approach is platelet-rich plasma (PRP) injection directly into the ovaries. The theory is that growth factors in PRP might “rejuvenate” dormant follicles. A study of 510 women with poor ovarian response (average age about 40) found that after PRP injection, ovarian reserve markers improved and roughly 13% achieved a sustained implantation or live birth. A meta-analysis pooling data from over 2,200 women reported improvements in egg counts and embryo numbers, with a live birth rate of about 11%. A very small study found that roughly half of poor responders who received PRP achieved spontaneous pregnancy, though several of those ended in miscarriage. PRP remains experimental, lacks large randomized trials, and is not widely available at fertility clinics. It is worth asking about if you are a poor responder, but set your expectations accordingly.

Your Partner’s Age Matters More Than You Might Think

The focus at 45 is understandably on the woman’s eggs, but paternal age quietly influences outcomes too. A retrospective study found that when the male partner was 40 or older, pregnancy rates in IVF were significantly lower and implantation rates dropped, even when semen parameters looked normal. Another study specifically looking at couples where the woman was 35 or older found that male partners 40 and over had significantly higher miscarriage rates and lower live birth rates, a pattern that persisted even after adjusting for confounding factors. If your partner is also in his forties, this compounding effect is worth discussing with your fertility specialist. Using donor sperm is an option that eliminates the paternal age factor, though it is a major personal decision.

Pregnancy Risks After 45

Getting pregnant is only the first challenge. Carrying a pregnancy safely at 45 and older involves genuinely elevated health risks that you and your doctor need to plan for. In one older study, nearly 47% of women over 45 experienced obstetric complications, with gestational diabetes and preeclampsia being the most common. A large U.S. population-based study found that women 45 and older had higher odds of cesarean delivery, gestational diabetes, preeclampsia, placenta previa, preterm labor, fetal growth restriction, and fetal demise compared to women under 35. They also carried higher odds of serious cardiovascular events, including heart failure and blood clots.

A Japanese cross-sectional study added an interesting nuance: the elevated risks of emergency cesarean delivery, preeclampsia, and preterm birth were actually greater in women who conceived naturally at 45 or older compared to those who conceived through assisted reproduction. One possible explanation is that women going through IVF receive closer prenatal monitoring and may be healthier on average at baseline, since clinics screen patients before treatment. Regardless of how you conceive, pregnancy at 45 requires high-risk obstetric care from the start. This is not a reason to avoid pregnancy, but it is a reason to go in with your eyes open and an excellent medical team behind you.

Clinic Policies and Age Caps

Access to fertility treatment at 45 is not guaranteed. About three-quarters of surveyed U.S. fertility clinics enforce a maximum maternal age for IVF with your own eggs, with a median cutoff of 45. For donor egg IVF, roughly 80% of clinics set a limit, typically around 52. Even for simpler treatments like IUI, about 43% of clinics had a maternal age cap, with a median of 46. These policies vary widely. Some clinics will treat women into their fifties with donor eggs; others decline treatment earlier. Outside the U.S., government-funded IVF programs often impose stricter age limits, and many countries are still adapting their regulations to the reality that more women are seeking treatment in their mid-forties and beyond.

If you are 45 and considering treatment, the first step is a consultation at one or more clinics to understand what they will and will not offer you. A preconception health evaluation, including cardiac screening and metabolic testing, is often required before treatment at this age and serves your safety regardless.

When to Consider Stopping

One of the hardest conversations in reproductive medicine is when to discontinue treatment. The emotional toll of repeated failed cycles is significant, and the psychological burden tends to be heavier for women, particularly when facing the biological pressure of age. The financial costs compound quickly. A modeling analysis found that adding PGT-A or using donor eggs improved cumulative live birth rates compared to standard IVF with your own eggs at 45, but all strategies involved substantial treatment costs. Some clinics recommend setting a limit in advance, whether that is a number of cycles, a financial ceiling, or a time point, so the decision to stop feels like a plan rather than a defeat. If your own eggs are the goal, a reasonable approach might be two to three retrieval cycles, ideally with egg banking and possibly DuoStim, before reassessing. If no viable embryos emerge, shifting to donor eggs or exploring other paths to parenthood deserves serious thought.